Physician profile
Warren M Jackman
NPI 1578531729
$2,267,395.81
in general payments reported to CMS, 2019-2025
5 companies · $121K in 2025
The $121K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196K · 2020: $115K · 2021: $98K · 2022: $1.2M · 2023: $315K · 2024: $264K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $346K · Consulting Fee: $291K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Travel and Lodging: $18K · Food and Beverage: $6,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $345,902.39 |
| Consulting Fee | $290,885.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,125.00 |
| Travel and Lodging | $18,499.13 |
| Food and Beverage | $6,143.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,404,658.05 | 2021-2024 | |
| Medical Device Business Services, INC. | $644,672.04 | 2019-2025 | Carto 3 |
| Boston Scientific Corporation | $110,345.44 | 2019-2025 | General - Therapies, Emblem Mri S-Icd, General - Ep |
| Biosense Webster, INC. | $88,772.35 | 2019-2025 | Carto 3, Thermocool Sf, Navistar |
| Biotronik INC. | $18,947.93 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Jackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.